Call for Chapters: Convergence of Population Health Management, Pharmacogenomics, and Patient-Centered Care

Editors

Anastasius Moumtzoglou, 'P & A Kyriakou' Children's Hospital, Greece

Call for Chapters

Proposals Submission Deadline: February 21, 2024
Full Chapters Due: May 8, 2024

Introduction

The quest for individualized treatment plans and customized medical research and discovery has become a ray of hope in the always-changing healthcare field, offering better patient results and increased well-being in general. Fundamentally, this transformative approach acknowledges that a person's reaction to treatments is greatly influenced by their genetic composition, lifestyle, and environmental circumstances. Personalized healthcare signifies a substantial shift from conventional, one-size-fits-all methods. It goes above and beyond standard practices by customizing interventions and therapies to each person's unique genetic and molecular profile. This strategy is based on identifying genetic, epigenomic, and clinical data, which is the cornerstone for comprehending how an individual's distinct genomic makeup affects their vulnerability to various illnesses. Understanding that every patient is unique, with unique genetics, lifestyle decisions, and environmental influences that significantly impact their health and reaction to medical treatments, is at the heart of this revolutionary idea. Fundamentally, personalized care aims to maximize health outcomes by encouraging proactive patient involvement, providing accurate and tailored interventions, and enabling people to take charge of their health. The three main pillars of this strategy are data-driven insights, genetic profiling, and advanced technology. Using these tools, healthcare professionals create individualized treatment programs that focus on treating the underlying causes of health problems in addition to treating their symptoms. Furthermore, the emphasis now includes preventative efforts in addition to treatment, ushering in a new era in healthcare where the needs of the individual come first. Personalized medicine, or PM, is a revolutionary concept in healthcare that has the potential to transform the industry while providing a host of advantages. Among the principal benefits are: • Marker-Assisted Diagnosis and Targeted Therapeutics. • Proactive Preventative Medicine (PMP). • Efficiency in Terms of Cost and Time. • Increased Treatment Efficacy. • Patient-Centric Care. From precise and effective therapies to proactive disease prevention, personalized medicine offers many benefits that ultimately improve patients' quality of life and streamline healthcare procedures. This strategy could lead to a more promising and patient-focused future for treatment. However, there are many obstacles to adopting personalized medicine (PM), which calls for considerable adjustments to the healthcare system. • Business Models and Infrastructure for Healthcare. • The Changing Roles of Patients and Doctors. • Information Technology Adoption. • Systems Approach and Integration. Even if personalized medicine has a lot of potential benefits, the issues listed above highlight the need for critical thought and aggressive measures to resolve them. All parties involved must be willing to embrace changes that can lead to a more patient-centric, proactive, and technologically sophisticated era of healthcare if PM is to be successfully adopted and integrated into healthcare systems. Moreover, the combined narrative of population health and personalized care sheds light on the rapidly changing healthcare environment, in which data, technology, moral considerations, and cooperative efforts are leading the way in a worldwide healthcare revolution. It emphasizes the significance of patient-centered healthcare, digital innovation, and appropriate data management. The idea of population health, a multidisciplinary approach that investigates the health outcomes of groups of people and the distribution of such outcomes within populations, is fundamental to this paradigm shift. 'Public health', the old-fashioned approach, connotes a relatively narrow field with activities carried out by agencies granted official functions. 'Population health' is a term with broader content and is related to a field relevant to the study of several important factors for health. As a result, it involves many terms, such as outcomes, disparities, determinants, and risk factors. Even though the term' population health' combines the concepts of health and population, every term has an essential meaning. The population is related to a group of persons being organized into numerous different units of analysis. Similarly, health was defined negatively, i.e., the absence of disease. Nowadays, the modern understanding also stresses the positive aspects, and health is related to all life issues. Whether population and public health are different or identical is debated. Nevertheless, population health is defined as health outcomes and their distribution. Population health management (PHM) has been defined as 'the technical field of endeavor which utilizes a variety of individual, organizational and cultural interventions to help improve the morbidity patterns (i.e., the illness and injury burden) and the health care use behavior of defined populations. It is differentiated from disease management because it includes: • More chronic conditions and diseases. • Uses a single point of contact and coordination and predictive modeling across multiple clinical conditions. Moreover, PHM is considered a broader term than disease management, as it includes: • Intensive care management for individuals at the highest level of risk. • Personal health management for those at lower levels of predicted health risk. while at the provider level, there are three highlighted components: • The leadership and the central care delivery role of the primary care physician. • The critical importance of patient activation. • The capacity expansion of care coordination. In this context, an organization should provide proactive, preventive and chronic care services to all managed patients to achieve all these requirements. Additionally, this should take place both during encounters of patients with the healthcare system and in between. Therefore, providers should maintain regular contact with their patients and support them in managing their health. Additionally, providers must manage patients at high risk to prevent the deterioration of their health and avoid the development of complications. Finally, if a provider-based PHM approach is followed, evidence-based protocols for diagnosing and treating patients consistently and cost-effectively are also required. The Federal Agency for Healthcare Research and Quality (AHRQ) developed the concept of 'practice-based population health' (PBPH). It defined it as "an approach to care that uses information on a group of patients within a primary care practice or group of practices to improve the care and clinical outcomes of patients within that practice.' Implementing health IT is among the essential components and requirements for planning and implementing PHM. The adoption of Electronic Health Records is just the first step toward the creation of the requisite infrastructure. However, many other IT applications are required to automate PHM, track results, and engage patients in health care. Additionally, IT systems should repeatedly be evaluated because of rapid technological changes, new government regulations and new approaches to patient management. AHRQ recommends health IT tools for the stratification and monitoring of populations as follows: • Target patients in greatest need of health services by stratifying the patients and narrowing subpopulations. • Make patient-related data actionable by generating alerts to the patients. • Make data actionable by generating alerts towards health providers about patient care needs. Conclusively, population health management is designed around the collective. However, nowadays, to truly drive high-quality care at lower cost, these endeavors must work for the individual, align with their personal goals and intermix with their reality. A significant driving force behind the enhancement of population health's position in the healthcare system was the COVID-19 pandemic. It emphasized how urgently healthcare has to adopt a more population-health-focused, data-driven, and holistic approach. The pandemic demonstrated the value of preventative healthcare and the critical contributions population data has made to the profession. It emphasized the need to use population data to strengthen predictive models, raised the issue of 'Big Data' and the relevant ethical considerations, and the importance of de-identified datasets. Finally, pharmaceutical sector advancements and the shift in healthcare toward personalized medicine (PM) are closely related, as patient data is used to develop and discover new drugs. Important issues include: • The Significance of Patient Data in Drug Discovery. • Including Noninvasive Molecular Imaging. • Modernizing Regulatory Framework. • Early Illness Detection with Liquid Biopsies. • Digitizing Healthcare and Improving IT Systems. • Integration of PM into the Healthcare System. • Post-Market Surveillance and Targeted Clinical Trials. • Utilize Digital Information to Build Sturdy Predictive Models. • Using Longitudinal Data to Make Better Conclusions. • Ensuring Equity and Ethical Standards. • Aiming for Interpretability and Explainability. • Interconnectivity and Standardization. • Reducing Healthcare Fragmentation. • Digitalization of Healthcare Services. • Promote the Creation of Global Data Standards.

Objective

The objective of the book is multifold. First, it will deal with the issues that prevent patient-centered care from being the norm and the need to systematically redesign legislation, organization, funding, information systems, education, and research. The aim is to examine patient-centred care design so that it becomes the logical choice. Secondly, it will address the greatest misconception about population health: it is not about the population. Ultimately, it is about the individual. It will show how to connect the dots from the science of individuality to improving health on a massive scale - a bottom-up approach that uses the technologies of cloud computing, Big Data and M-Health. Thirdly, it will examine the dramatic change and the relevant great fuss that is difficult to cut through in digitalization the pharmaceutical sector has experienced.

Target Audience

The book intends to provide a compendium of terms, definitions and explanations of concepts, processes and acronyms. Additionally, it will present chapters (each chapter consisting of 7,000-10,000 words) authored by leading experts, offering an in-depth description of key terms and concepts. It intends to: • Support students in understanding the effect of various domains of knowledge relating to healthcare. • Help healthcare professionals better understand the needs of their patients. • Act as an assistant for patients to derive more benefits from their healthcare. • Encourage e-health systems' designers and managers to ground everyday practice on the science of individuality. The prospective audience includes undergraduate and extended degree programs students, graduate students of health care quality and health services management, executive education and continuing education, health care managers and health professionals.

Recommended Topics

• Mobile Computing, Artificial Intelligence and Machine Learning. • Marker-Assisted Diagnosis and Targeted Therapeutics. • Proactive Preventative Medicine (PMP). • Efficiency in Terms of Cost and Time. • Increased Treatment Efficacy. • Patient-Centric Care. • Business Models and Infrastructure for Healthcare. • The Changing Roles of Patients and Doctors. • Information Technology Adoption. • Systems Approach and Integration. • Using Population Data to Strengthen Predictive Models. • The Revolution in 'Big Data' and Ethical Considerations. • De-identified datasets. • The Significance of Patient Data in Drug Discovery. • Including Noninvasive Molecular Imaging. • Modernizing Regulatory Frameworks. • Early Illness Detection with Liquid Biopsies. • Digitizing Healthcare and Improving IT Systems. • Integration of PM into the Healthcare System. • Post-Market Surveillance and Targeted Clinical Trials. • Utilize Digital Information to Build Sturdy Predictive Models. • Using Longitudinal Data to Make Better Conclusions. • Ensuring Equity and Ethical Standards. • Aiming for Interpretability and Explainability. • Interconnectivity and Standardization. • Reducing Healthcare Fragmentation. • Digitalization of Healthcare Services. • Promote the Creation of Global Data Standards. • The social determinants of health. • Overview of public health (definition, history, and general trends). • Population health, population health management & disease management. • Roles of healthcare professionals in population health management. • Healthcare reform & Population health management. • Population health management & Primary care. • Population health management & Patient Activation. • Population health management & Quality improvement. • Population health management & Digital revolution. • Automating population health management & the quality of care. • Population health management & Cloud computing. • Population Health Management & Big Data. • Population Health Management & M-Health. • Population health management & Cognitive computing. • Population health management & Electronic health records. • Population Health Management & Telemedicine. • Population Health Management & Wearables. • Population health management & Geographic information systems. • Population health management & Decision support systems. • Population health management & Patient-centered medical homes. • Population health management & Predictive analytics. • Population health management & Prescriptive analytics. • Population health management & Text analytics. • The role of patients in the advisory board of pharmaceutical companies. • The digital strategy regarding pills. • In silico trials. • Virtual reality and painkillers. • Precision medicine through pharmacogenomics. • 3D printing drugs. • The need for new drug regulations. • Drug prescription and augmented reality.

Submission Procedure

Researchers and practitioners are invited to submit on or before February 21, 2024, a chapter proposal of 1,000 to 2,000 words clearly explaining the mission and concerns of his or her proposed chapter. Authors will be notified by March 31, 2024 about the status of their proposals and sent chapter guidelines. Full chapters are expected to be submitted by May 8, 2024, and all interested authors must consult the guidelines for manuscript submissions at https://www.igi-global.com/publish/contributor-resources/before-you-write/ prior to submission. All submitted chapters will be reviewed on a double-blind review basis. Contributors may also be requested to serve as reviewers for this project.

Note: There are no submission or acceptance fees for manuscripts submitted to this book publication, Convergence of Population Health Management, Pharmacogenomics, and Patient-Centered Care. All manuscripts are accepted based on a double-blind peer review editorial process.

All proposals should be submitted through the eEditorial Discovery® online submission manager.



Publisher

This book is scheduled to be published by IGI Global (formerly Idea Group Inc.), an international academic publisher of the "Information Science Reference" (formerly Idea Group Reference), "Medical Information Science Reference," "Business Science Reference," and "Engineering Science Reference" imprints. IGI Global specializes in publishing reference books, scholarly journals, and electronic databases featuring academic research on a variety of innovative topic areas including, but not limited to, education, social science, medicine and healthcare, business and management, information science and technology, engineering, public administration, library and information science, media and communication studies, and environmental science. For additional information regarding the publisher, please visit https://www.igi-global.com. This publication is anticipated to be released in 2025.



Important Dates

February 21, 2024: Proposal Submission Deadline
March 31, 2024: Notification of Acceptance
May 8, 2024: Full Chapter Submission
July 10, 2024: Review Results Returned
August 21, 2024: Final Acceptance Notification
September 4, 2024: Final Chapter Submission



Inquiries

Anastasius Moumtzoglou 'P & A Kyriakou' Children's Hospital anastasius.moumtzoglou@gmail.com

Classifications


Business and Management; Computer Science and Information Technology; Education; Medicine and Healthcare; Social Sciences and Humanities
Back to Call for Papers List